Chromoendoscopy Agents Market

Chromoendoscopy Agents Market (Product Type: Absorptive Agents, Contrast Agents, and Reactive Agents; Application: Esophageal, Gastric, and Colorectal; and End User: Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Diagnostic Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Infected Fomites Increasing Risk of Coronavirus Transmission during GI Endoscopy

The virus’ stability, characteristics, and modes of transmission through fomites and air droplets make gastrointestinal (GI) endoscopy a high-risk procedure with potential of COVID-19 virus transmission. Such findings are concerning stakeholders in the chromoendoscopy agents market. They are increasing efforts to maintain stable supply chains for products, since healthcare professionals are faced with critical patients in emergency cases.

There is a high risk of COVID-19 transmission through infected fomites such as stethoscope, endoscope, and thermometer. Since both patient and healthcare professionals are at a risk of contracting the novel infection, healthcare systems and companies in the chromoendoscopy agents market are gaining awareness about simple precautionary measures. These include the use of double surgical masks to prevent infection in endoscopy. As such, there is a need for more studies with robust design to ascertain the exact risk of coronavirus transmission during the GI endoscopy.

chromoendoscopy agents market infographic

Request a sample to get extensive insights into the Chromoendoscopy Agents Market

Combination of Dye-based Virtual Chromoendoscopy Improving Medical Outcomes

The chromoendoscopy agents market is projected to expand at a modest CAGR of 3.4% during the forecast period. Dye-based chromoendoscopy is considered the gold standard for accurate detection and characterization of lesions throughout the gastrointestinal tract (GIT). However, the most challenging feature regarding dye-based chromoendoscopy as compared to current virtual chromoendoscopy technique is the longer procedural time. Thus, novel trials are being conducted by researchers, scientists, and biologists. For instance, orally ingested tablets of methylene blue combined with the bowel preparation for screening colposcopy have showed promising results in increasing adenoma detection.

Targeted biopsies of any mucosal abnormalities using dye-based chromoendoscopy, along with a combination of virtual chromoendoscopy with high magnification imaging is increasing medical outcomes.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Good Bowel Preparation, Diagnostic Yield Helps Improve Patient Outcomes

Chromoendoscopy is playing a major role in modern endoscopic imaging. This technique aids the endoscopist in highlighting and characterizing lesions in the GIT. Spraying catheters allow the most controlled and precise application of the dye as a fine mist onto the GIT surface. In colonoscopy, good bowel preparation is critical. This is being achieved using spasmolytic agents such as scopolamine or glucagon, which can be used to avoid bowel peristalsis and an uneven distribution of the dye in some cases.

Companies in the chromoendoscopy agents market are competing to demonstrate good diagnostic yield in the evaluation of dysplastic lesions in Barrett’s oesophagus (BO) and oesophageal adenocarcinoma by enabling targeted biopsies of suspicious areas. Companies in the chromoendoscopy agents market are increasing focus on methylene blue staining to assess areas of BO.

Optical Chromoendoscopy, Technological Developments in Phytodynamic Therapy Boosting Market Growth

Chromoendoscopy is emerging as an alternative to fluorescence spectroscopy, fluorescence endoscopy, and optical coherence tomography. This is evident since companies in the chromoendoscopy agents market are increasing the availability of equipment needed in chromoendoscopy. The interest in chromoendoscopy is being heightened with the development of technologies such as endoscopic mucosal resection and phytodynamic therapy that require precise visual tissue characterization.

Chromoendoscopy is being used in conjunction with developments in endoscopic imaging such as confocal endomicroscopy, confocal endocytoscopy, and magnification endoscopy. Companies in the chromoendoscopy agents market are benefitting from these findings, as these techniques are simple, quick, inexpensive, and safe. On the other hand, acetic acid is being used in the detection of dysplasia within a region of the BO. Companies in the chromoendoscopy agents market are increasing their R&D in optical chromoendoscopy, which is a method that involves digital image processing performed by an endoscope and can produce nearly comparable results to spray chromoendoscopy.

Effective Diagnosis of Colorectal Cancer Triggers Demand for Dye-based Chromoendoscopy

Colonoscopy is being associated with decline in colorectal cancer risk and mortality with the help of detection and resection of precursor lesions. However, its role for preventing the colorectal cancer still has limitations. Companies in the chromoendoscopy agents market are capitalizing on this opportunity to deploy image enhancement techniques to improve the diagnostic yield of colonoscopy and optimize the management of colorectal lesions.

Colonoscopy is one of the most effective diagnostic and therapeutic tools for the prevention of colorectal cancer by detection and removal of precursor lesions. Companies in the chromoendoscopy agents market are increasing the availability of dye-based chromoendoscopy to help oncologists advance in diagnosis of colorectal cancer.

Healthcare Companies Adapting to Shift from Chromoendoscopy to VCE

The virtual chromoendoscopy (VCE) is gaining popularity in the chromoendoscopy agents market to augment the spatial variance of light absorption and scattering properties of tissue in diagnostic and therapeutic applications. It has been found that VCE is emerging as an alternative to conventional chromoendoscopy where the stain agents are necessary. Such findings are influencing the growth of the chromoendoscopy agents market. VCE is capable of detecting spatial variations in light adsorption and scattering of target tissue, which helps in distinguishing abnormal and healthy tissue.

Introduction and adoption of virtual or electronic chromoendoscopy have made dye-based chromoendoscopy less relevant in the day-to-day clinical practice. Healthcare companies are increasing efforts to adapt to such changes in the market landscape. Virtual chromoendoscopy is found to be technically less cumbersome, easy in implementation, and saves time. VCE has become a recurring trend in the market, since the method involves image processing to enhance the vascular pattern of the mucosa. Nevertheless, chromoendoscopy still plays a major role in several conditions.

Contrast Agents Gaining Relevancy in Colon Chromoendoscopy

For the detection of colorectal lesions, two main substances usually indigo carmine, a contrast agent, and methylene blue, an absorptive agent, are used. Manufacturers are increasing their production capabilities in absorptive agents and contract agents to improve clinical numbers, owing to colorectal cancer. As such, crystal violet is used along with the magnification of characterization of lesions in which sub-mucosal invasion (SMI) is suspected.

Before the drop-wise instillation of crystal violet, a mucolytic agent should always be applied onto the lesion to avoid false images of invasive pattern in areas where the dye is not absorbed. Indigo carmine, a contrast agent is gaining relevancy in colon chromoendoscopy and targeted chromoendoscopy. Absorbents, such as methylene blue are being used for the pan-colonic chromoendoscopy.

chromoendoscopy agents market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Chromoendoscopy Agents Market

Analysts’ Viewpoint

Several guidelines and recommendations for prevention of the COVID-19 transmission during endoscopy procedures are being followed by healthcare professionals. The chromoendoscopy agents market is expected to reach US$ 181.2 Mn by 2031. However, the interpretation of findings is not always straightforward, and the impact of chromoendoscopy on clinical outcomes with context to standard endoscopic and histologic methods lacks evidence. Hence, companies should increase awareness about the combination of dye-based and virtual chromoendoscopy with high magnification imaging and increase large controlled trials in the same to improve patient outcomes. The VCE uses narrow band imaging to provide enhanced version of the vascular pattern of the mucosa.

Chromoendoscopy Agents Market: Overview

  • This report analyzes the current scenario and future prospects of the global chromoendoscopy agents market. Rise in prevalence of gastrointestinal diseases, technological advancements in imaging techniques, surge in awareness among people about preventive measures of cancer, and increase in the number of endoscopy procedures are factors projected to propel the global market during the forecast period.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments of the global chromoendoscopy agents market. It also provides information and data analysis of the chromoendoscopy agents market about segments based on product type, application, and end user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global chromoendoscopy agents market
  • The report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the global chromoendoscopy agents market
  • The report on the chromoendoscopy agents market offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global chromoendoscopy agents market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global chromoendoscopy agents market.

Chromoendoscopy Agents Market: Key Segments

  • In terms of product type, the global chromoendoscopy agents market has been classified into absorptive agents, contrast agents, and reactive agents. The absorptive agents segment is projected to account for major share of the market during the forecast period. Absorptive agents improve the recognition of minute changes in the surface pattern by enhancing the contrast of raised and deepened area. This facilitates the visualization and detection of dysplastic and malignant lesions in the gastrointestinal tract.
  • Based on application, the global chromoendoscopy agents market has been categorized into esophageal, gastric, and colorectal. The colorectal segment dominated the market in 2020. This can be attributed to increase in cases of colorectal cancer and rise in preventive measures for colorectal cancer by the governments of developed countries.
  • In terms of end user, the global chromoendoscopy agents market has been divided into hospitals, ambulatory surgery centers, specialty clinics, diagnostic centers, and others. The hospitals segment is projected to account for major share of the market. Large share of the segment can be ascribed to increase in the number of endoscopy procedures performed in hospitals.
  • Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Chromoendoscopy Agents Market: Regional Outlook

  • In terms of region, the global chromoendoscopy agents market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, Spain, Italy, France, Switzerland, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The chromoendoscopy agents market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The chromoendoscopy agents market study also covers the competitive scenario in these regions.

Companies Covered in Chromoendoscopy Agents Market Report

  • Key players in the global chromoendoscopy agents market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the chromoendoscopy agents market report are
    • Cosmo Pharmaceuticals NV.
    • Merck KGaA
    • Thermo Fisher Scientific
    • Provepharm Life Solutions
    • Enzo Life Sciences, Inc.
    • American Regent, Inc.
    • Micro-Tech Endoscopy
    • Cerba Research
    • Sisco Research Laboratories Pvt. Ltd.
    • LobaChemie Pvt. Ltd.
    • among others

Chromoendoscopy Agents Market – Segmentation

Product Type
  • Absorptive Agents
  • Contrast Agents
  • Reactive Agents
Application
  • Esophageal
  • Gastric
  • Colorectal
End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Diagnostic Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of chromoendoscopy agents market?

The global chromoendoscopy agents market was worth US$ 100 Mn and is projected to reach a value of US$ 200 Mn by the end of 2031

What is the anticipated CAGR of the chromoendoscopy agents market in the forecast period?

Chromoendoscopy agents market is anticipated to grow at a CAGR of 4% during the forecast period

Which region is expected to project the highest market share in the global chromoendoscopy agents market?

North America accounted for a major share of the global chromoendoscopy agents market

What are the key driving factors for the growth of the chromoendoscopy agents market?

Chromoendoscopy agents market is driven by increase in incidence of gastrointestinal diseases is a major factor expected to drive the global market during the forecast period

Who are the key players in the global chromoendoscopy agents market?

Key players in the global chromoendoscopy agents market include Cosmo Pharmaceuticals NV., Merck KGaA, Thermo Fisher Scientific, Provepharm Life Solutions, Enzo Life Sciences, Inc., American Regent, Inc., Micro-Tech Endoscopy, Cerba Research, Sisco Research Laboratories Pvt. Ltd., and LobaChemie Pvt. Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Chromoendoscopy Agents Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Chromoendoscopy Agents Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

        5.2. Top 3 players operating in the market space

        5.3. Regulatory Scenario

        5.4. Pricing Analysis

        5.5. Patients Journey Landscape

        5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Chromoendoscopy Agents Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Absorptive Agents

            6.3.2. Contrast Agents

            6.3.3. Reactive Agents

        6.4. Market Attractiveness Analysis, by Product Type 

    7. Global Chromoendoscopy Agents Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Colorectal

            7.3.2. Esophageal

            7.3.3. Gastric

        7.4. Market Attractiveness Analysis, by Application 

    8. Global Chromoendoscopy Agents Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast By End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Ambulatory Surgery Centers

            8.3.3. Specialty Clinics

            8.3.4. Diagnostic Centers

            8.3.5. Others

        8.4. Market Attractiveness Analysis, by End-user 

    9. Global Chromoendoscopy Agents Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America 

            9.2.2. Europe 

            9.2.3. Asia Pacific 

            9.2.4. Latin America 

            9.2.5. Middle East & Africa 

        9.3. Market Attractiveness Analysis, by Country/Region

    10. North America Chromoendoscopy Agents Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Absorptive Agents

            10.2.2. Contrast Agents

            10.2.3. Reactive Agents

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Colorectal

            10.3.2. Esophageal

            10.3.3. Gastric

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Ambulatory Surgery Centers

            10.4.3. Specialty Clinics

            10.4.4. Diagnostic Centers

            10.4.5. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis 

            10.6.1. By Product Type 

            10.6.2. By Application 

            10.6.3. By End-user 

            10.6.4. By Country

    11. Europe Chromoendoscopy Agents Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Absorptive Agents

            11.2.2. Contrast Agents

            11.2.3. Reactive Agents

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Colorectal

            11.3.2. Esophageal

            11.3.3. Gastric

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Ambulatory Surgery Centers

            11.4.3. Specialty Clinics

            11.4.4. Diagnostic Centers

            11.4.5. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Russia

            11.5.7. Switzerland

            11.5.8. Rest of Europe

        11.6. Market Attractiveness Analysis 

            11.6.1. By Product Type 

            11.6.2. By Application 

            11.6.3. By End-user 

            11.6.4. By Country/Sub-region

    12. Asia Pacific Chromoendoscopy Agents Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Absorptive Agents

            12.2.2. Contrast Agents

            12.2.3. Reactive Agents

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Colorectal

            12.3.2. Esophageal

            12.3.3. Gastric

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Ambulatory Surgery Centers

            12.4.3. Specialty Clinics

            12.4.4. Diagnostic Centers

            12.4.5. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis 

            12.6.1. By Product Type 

            12.6.2. By Application 

            12.6.3. By End-user 

            12.6.4. By Country/Sub-region

    13. Latin America Chromoendoscopy Agents Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Absorptive Agents

            13.2.2. Contrast Agents

            13.2.3. Reactive Agents

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Colorectal

            13.3.2. Esophageal

            13.3.3. Gastric

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Ambulatory Surgery Centers

            13.4.3. Specialty Clinics

            13.4.4. Diagnostic Centers

            13.4.5. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis 

            13.6.1. By Product Type 

            13.6.2. By Application 

            13.6.3. By End-user 

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Chromoendoscopy Agents Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Absorptive Agents

            14.2.2. Contrast Agents

            14.2.3. Reactive Agents

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Colorectal

            14.3.2. Esophageal

            14.3.3. Gastric

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Ambulatory Surgery Centers

            14.4.3. Specialty Clinics

            14.4.4. Diagnostic Centers

            14.4.5. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis 

            14.6.1. By Product Type 

            14.6.2. By Application 

            14.6.3. By End-user 

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Company Profiles

            15.1.1. Cosmo Pharmaceuticals NV

                15.1.1.1. Company Overview

                15.1.1.2. Company Financials

                15.1.1.3. Growth Strategies

                15.1.1.4. SWOT Analysis

            15.1.2. Provepharm Life Solutions

                15.1.2.1. Company Overview

                15.1.2.2. Company Financials

                15.1.2.3. Growth Strategies

                15.1.2.4. SWOT Analysis

            15.1.3. Enzo Life Sciences

                15.1.3.1. Company Overview

                15.1.3.2. Company Financials

                15.1.3.3. Growth Strategies

                15.1.3.4. SWOT Analysis

            15.1.4. Sisco Research Laboratories Pvt. Ltd.

                15.1.4.1. Company Overview

                15.1.4.2. Company Financials

                15.1.4.3. Growth Strategies

                15.1.4.4. SWOT Analysis

            15.1.5. Thermo Fisher Scientific

                15.1.5.1. Company Overview

                15.1.5.2. Company Financials

                15.1.5.3. Growth Strategies

                15.1.5.4. SWOT Analysis

            15.1.6. LobaChemie Pvt. Ltd.

                15.1.6.1. Company Overview

                15.1.6.2. Company Financials

                15.1.6.3. Growth Strategies

                15.1.6.4. SWOT Analysis

            15.1.7. Merck KGaA

                15.1.7.1. Company Overview

                15.1.7.2. Company Financials

                15.1.7.3. Growth Strategies

                15.1.7.4. SWOT Analysis

            15.1.8. Cerba Research

                15.1.8.1. Company Overview

                15.1.8.2. Company Financials

                15.1.8.3. Growth Strategies

                15.1.8.4. SWOT Analysis

            15.1.9. American Regent, Inc.

                15.1.9.1. Company Overview

                15.1.9.2. Company Financials

                15.1.9.3. Growth Strategies

                15.1.9.4. SWOT Analysis

            15.1.10. Micro-Tech Endoscopy

                15.1.10.1. Company Overview

                15.1.10.2. Company Financials

                15.1.10.3. Growth Strategies

                15.1.10.4. SWOT Analysis

    List of Tables

    Table 01: Staining agents for chromoendoscopy

    Table 02: Cost associated with Chromoendoscopy Diagnostic Procedure

    Table 03: Chromoendoscopy Product Specifications

    Table 04: Spray catheters for chromoendoscopy

    Table 05: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 06: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by Application, 2017–2031

    Table 07: Global Chromoendoscopy Agents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031

    Table 08: Global Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 09: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 10: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 15: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 23: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 25: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 27: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 28: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figure

    Figure 01: Global Chromoendoscopy Agents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 02: Global Chromoendoscopy Agents Market Value Share, by Region, 2020

    Figure 03: Global Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 04: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Absorptive Agents , 2017–2031

    Figure 05: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Cardiology, 2017–2031

    Figure 06: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Neurology, 2017–2031

    Figure 07: Global Chromoendoscopy Agents Market Attractive Analysis, by Product Type, (2021–2031)

    Figure 08: Global Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 09: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Colorectal, 2017–2031

    Figure 10: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Esophageal, 2017–2031

    Figure 11: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Gastric, 2017–2031

    Figure 12: Global Chromoendoscopy Agents Market Attractive Analysis, by Application, (2021–2031)

    Figure 13: Global Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 14: Global Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 15: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Hospitals, 2017–2031

    Figure 16: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017–2031

    Figure 17: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Specialty Clinics, 2017–2031

    Figure 18: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Diagnostic Centers, 2017–2031

    Figure 19: Global Chromoendoscopy Agents Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 20: Global Chromoendoscopy Agents Market Attractive Analysis, by End-user, (2021–2031)

    Figure 21: Global Chromoendoscopy Agents Market Value Share Analysis, by Region, 2020 and 2031

    Figure 22: Global Chromoendoscopy Agents Market Attractiveness Analysis, by Region, 2021–2031

    Figure 23: North America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

    Figure 24: North America Chromoendoscopy Agents Market Value Share Analysis, by Country, 2020 and 2031

    Figure 25: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Country, 2021–2031

    Figure 26: North America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 27: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 28: North America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 29: North America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 30: North America Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 31: North America Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 32: Europe Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

    Figure 33: Europe Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 34: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 35: Europe Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 36: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 37: Europe Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 38: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 39: Europe Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 40: Europe Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 41: Asia Pacific Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

    Figure 42: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 43: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 44: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 45: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 46: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 47: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 48: Asia Pacific Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 49: Asia Pacific Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 50: Latin America Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

    Figure 51: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 52: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 53: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 54: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 55: Latin America Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 56: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 57: Latin America Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 58: Latin America Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 59: Middle East & Africa Chromoendoscopy Agents Market Value (US$ Mn) Forecast, 2017–2031

    Figure 60: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 61: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 62: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 63: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 64: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by Application, 2020 and 2031

    Figure 65: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by Application, 2021–2031

    Figure 66: Middle East & Africa Chromoendoscopy Agents Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 67: Middle East & Africa Chromoendoscopy Agents Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 68: Position Analysis, 2020, by Tier and Size of the Company

    Figure 69: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 70: Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 72: Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 73: Breakdown of Net Sales (%), by Geography, 2019

    Figure 74: Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 75: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 76: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 77: Breakdown of Net Sales (%), by Geography, 2020

    Figure 78: Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 79: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 81: Breakdown of Net Sales (%), by Geography, 2020

    Figure 82: Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 83: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Copyright © Transparency Market Research, Inc. All Rights reserved